These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16416231)

  • 1. Relapse of inflammatory bowel disease associated with use of nonsteroidal anti-inflammatory drugs.
    Meyer AM; Ramzan NN; Heigh RI; Leighton JA
    Dig Dis Sci; 2006 Jan; 51(1):168-72. PubMed ID: 16416231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Nonsteroidal Anti-Inflammatory Drugs in Exacerbations of Inflammatory Bowel Disease.
    Long MD; Kappelman MD; Martin CF; Chen W; Anton K; Sandler RS
    J Clin Gastroenterol; 2016 Feb; 50(2):152-6. PubMed ID: 26485106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerance of nonsteroidal antiinflammatory drugs in patients with inflammatory bowel disease.
    Bonner GF; Walczak M; Kitchen L; Bayona M
    Am J Gastroenterol; 2000 Aug; 95(8):1946-8. PubMed ID: 10950040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsteroidal anti-inflammatory drugs and exacerbations of inflammatory bowel disease.
    Kvasnovsky CL; Aujla U; Bjarnason I
    Scand J Gastroenterol; 2015 Mar; 50(3):255-63. PubMed ID: 25314574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of infliximab in treating patients with ulcerative colitis: experiences from a single medical center in southern China.
    Zhou YL; Xie S; Wang P; Zhang T; Lin MY; Tan JS; Zhi FC; Jiang B; Chen Y
    J Dig Dis; 2014 Sep; 15(9):483-90. PubMed ID: 24828856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discontinuation of anti-tumor necrosis factor therapy in inflammatory bowel disease patients: a prospective observation.
    Bortlik M; Duricova D; Machkova N; Hruba V; Lukas M; Mitrova K; Romanko I; Bina V; Malickova K; Kolar M; Lukas M
    Scand J Gastroenterol; 2016; 51(2):196-202. PubMed ID: 26329773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A long-term cohort study of nonsteroidal anti-inflammatory drug use and disease activity in outpatients with inflammatory bowel disease.
    Bonner GF; Fakhri A; Vennamaneni SR
    Inflamm Bowel Dis; 2004 Nov; 10(6):751-7. PubMed ID: 15626893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do non-steroidal anti-inflammatory drugs cause exacerbations of inflammatory bowel disease?
    Feagins LA; Cryer BL
    Dig Dis Sci; 2010 Feb; 55(2):226-32. PubMed ID: 19924534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of mesalamine and nicotine in the treatment of inflammatory bowel disease.
    Bonapace CR; Mays DA
    Ann Pharmacother; 1997; 31(7-8):907-13. PubMed ID: 9220055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolate mofetil therapy in the management of inflammatory bowel disease--a retrospective case series and review.
    Smith MR; Cooper SC
    J Crohns Colitis; 2014 Aug; 8(8):890-7. PubMed ID: 24507162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease.
    Evans JM; McMahon AD; Murray FE; McDevitt DG; MacDonald TM
    Gut; 1997 May; 40(5):619-22. PubMed ID: 9203940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual therapy with infliximab and immunomodulator reduces one-year rates of hospitalization and surgery among veterans with inflammatory bowel disease.
    Abraham NS; Richardson P; Castillo D; Kane SV
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1281-7. PubMed ID: 23792295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing the relapse of patients with inflammatory bowel disease.
    Miner PB
    Am J Gastroenterol; 1997 Dec; 92(12 Suppl):1S-4S. PubMed ID: 9395345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms and the cardiovascular risk of non-steroidal anti-inflammatory drugs.
    St Germaine CG; Bogaty P; Boyer L; Hanley J; Engert JC; Brophy JM
    Am J Cardiol; 2010 Jun; 105(12):1740-5. PubMed ID: 20538124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of NSAIDs Use and Their Association with Other Analgesic Use in CKD.
    Zhan M; St Peter WL; Doerfler RM; Woods CM; Blumenthal JB; Diamantidis CJ; Hsu CY; Lash JP; Lustigova E; Mahone EB; Ojo AO; Slaven A; Strauss L; Taliercio JJ; Winkelmayer WC; Xie D; Fink JC;
    Clin J Am Soc Nephrol; 2017 Nov; 12(11):1778-1786. PubMed ID: 28811297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of nonsteroidal anti-inflammatory drugs with first occurrence of heart failure and with relapsing heart failure: the Rotterdam Study.
    Feenstra J; Heerdink ER; Grobbee DE; Stricker BH
    Arch Intern Med; 2002 Feb; 162(3):265-70. PubMed ID: 11822918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome of inflammatory bowel disease patients with deep remission after discontinuation of TNFα-blocking agents.
    Molander P; Färkkilä M; Kemppainen H; Blomster T; Jussila A; Mustonen H; Sipponen T
    Scand J Gastroenterol; 2017 Mar; 52(3):284-290. PubMed ID: 27806638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of celecoxib in patients with ulcerative colitis in remission: a randomized, placebo-controlled, pilot study.
    Sandborn WJ; Stenson WF; Brynskov J; Lorenz RG; Steidle GM; Robbins JL; Kent JD; Bloom BJ
    Clin Gastroenterol Hepatol; 2006 Feb; 4(2):203-11. PubMed ID: 16469681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.